Live feed
Filing
SC 13G/A
SC 13G/A0001104659-22-018708·Theravance Biopharma, Inc.
Schedule 13G ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,299,823
- Percent of class
- 8.5500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-018708
- Form type
- SC 13G/A
- Filer
- Theravance Biopharma, Inc.
- CIK
- CIK 1583107
- Filed
- Feb 10, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership